HDTV (Hypertension Dailysis and Transplantation Foundation) Partnership

Thu, 07 Aug 2025 02:11:42 +0300

A significant proportion of the founding members of the JEIMP editorial board concurrently serve as distinguished members of both the Board of Directors and the Scientific Committee of the Hypertension, Dialysis and Transplantation Foundation (HDTV). This overlap not only reflects the shared vision and longstanding collaboration between JEIMP and HDTV but also provides a solid foundation for joint scientific advancement and academic excellence in our field. This partnership does not influence editorial decisions, peer review processes, or publication outcomes, which remain under the full and independent authority of the JEIMP editorial leadership.

In recognition of this close relationship, JEIMP will henceforth continue its mission in direct and formal partnership with HDTV. Through a unanimous and formal resolution adopted by its Board of Directors on August 1, 2025, HDTV has designated JEIMP as its sole official journal.

It is important to note, however, that all publishing and broadmark rights of JEIMP will remain under the stewardship of MKD Digital Publishing. We believe that this collaborative model, anchored in shared leadership yet respecting organizational autonomy, will further enhance the impact and reach of JEIMP, ensuring that it remains at the forefront of scientific publishing in our specialty.

www.hdtv.info

Guidelines and Recommendations for Authors Using AI in Manuscript Preparation

Sun, 24 Nov 2024 22:28:25 +0300

Guidelines and Recommendations for Authors Using AI in Manuscript Preparation

Integrating Artificial Intelligence (AI) in academic writing has brought significant advantages, including enhanced productivity, improved language quality, and efficient data analysis. However, the use of AI in manuscript preparation requires transparency, ethical considerations, and adherence to academic integrity standards.

This article aims to provide guidance and recommendations for authors who utilize AI tools to prepare manuscripts for submission to The Journal of European Internal Medicine Professionals (JEIMP).

1. Transparency and Disclosure

Authors are required to disclose the use of AI tools during manuscript preparation. This includes, but is not limited to:

Writing assistance (e.g., grammar and style checks by AI tools like Grammarly or ChatGPT).
Data analysis or visualization (e.g., AI-based statistical software).
Literature search and summarization.

Recommendation: Include a statement in the manuscript's "Acknowledgments" or "Methods" section specifying the AI tools used and their purpose. For example: "This manuscript was prepared with assistance from [AI Tool Name], used for [specific purpose, e.g., language editing, data analysis, or figure preparation]."

2. Ethical Use of AI

AI tools should be used as supportive instruments rather than as substitutes for critical thinking and original contributions. Authors must ensure that:

AI-generated content is fact-checked and validated for accuracy.
The manuscript reflects the authors’ intellectual effort, interpretation, and conclusions.
AI is not used to fabricate data, falsify results, or plagiarize existing works.

Caution: Misuse of AI, such as generating false citations or unverified information, constitutes academic misconduct and will lead to rejection of the manuscript.

3. Accountability and Authorship

The use of AI does not confer authorship. Human authors remain responsible for:

The originality and integrity of the manuscript.
Addressing ethical concerns related to the use of AI.
Ensuring compliance with journal guidelines and ethical standards.

Recommendation: All authors should review and agree upon the AI-assisted contributions before submission. They must ensure that the use of AI does not compromise the scientific or ethical quality of the manuscript.

4. Limitations of AI in Manuscript Preparation

AI tools have limitations, including:

Lack of subject-specific expertise.
Inability to fully understand nuanced arguments or novel hypotheses.
Potential biases in generated content.

Advice: Authors should use AI as a complement, not a replacement, to their expertise. Rely on peer collaboration and expert feedback to refine the manuscript.

5. Journal Policy on AI

The Journal of European Internal Medicine Professionals (JEIMP) supports the responsible use of AI in academic writing, provided it adheres to the following principles:

Full disclosure of AI use in the manuscript.
Strict adherence to ethical standards.
Verification and accountability for AI-assisted content by human authors.

Manuscripts that fail to disclose AI usage or demonstrate ethical lapses will be subject to editorial action, including rejection or retraction.

6. Resources and Training

To support authors in responsibly using AI tools, The Journal of European Internal Medicine Professionals (JEIMP) recommends:

Reviewing AI capabilities and limitations through credible sources.
Participating in workshops or webinars on academic integrity and AI usage.
Consulting editorial teams for specific questions about AI-related policies.

Translation

Mon, 27 Nov 2023 16:13:47 +0300

Journal of European Internal Medicine Professionals: Announcements